Daniel Walter Zumofen1,2, Tommaso Guffi3, Christian Epple4, Birgit Westermann1, Anna-Katharina Krähenbühl5, Susanne Zabka1, Ethan Taub1, Daniel Bodmer6, Luigi Mariani1. 1. Department of Neurosurgery, Basel University Hospital, Basel, Switzerland. 2. Division of Diagnostic and Interventional Neuroradiology, Department of Radiology, Basel University Hospital, Basel, Switzerland. 3. Faculty of Medicine, University of Lausanne, Lausanne, Switzerland. 4. Department of Biomedicine, Basel University Hospital, Basel, Switzerland. 5. Department of Neurosurgery, Bern University Hospital, Bern, Switzerland. 6. Department of Otolaryngology, Basel University Hospital, Basel, Switzerland.
Abstract
BACKGROUND: The goals of treating Koos grade IV vestibular schwannomas are to relieve brainstem compression, preserve or restore neurological function, and achieve long-term tumor control while minimizing tumor- and treatment-related morbidity. OBJECTIVE: To propose a treatment paradigm involving the intentional near-total removal of Koos grade IV vestibular schwannomas, in which a small amount of residual tumor is not dissected off the cisternal portion of the facial nerve. Patients are then followed by a wait-and-scan approach. Any subsequent volumetric progression of the residual tumor is treated with radiosurgery. METHODS: This is a case series of 44 consecutive unselected patients who underwent intended near-total resection of a Koos grade IV vestibular schwannoma through a retrosigmoid approach from January 2009 to December 2015. Pre- and postoperative volumetric analyses were performed on routine magnetic resonance imaging sequences (constructive interference in steady state and gadolinium-enhanced T1-weighted sequence). RESULTS: The mean preoperative tumor volume was 10.9 cm3. The mean extent of resection was 89%. At the last clinical follow-up, facial nerve function was good [House and Brackmann (HB) I-II] in 89%, fair (HB III) in 9%, and poor (HB IV-VI) in 2% of the patients. At the last radiological follow-up, the residual tumor had become smaller or remained the same size in 84% of patients. Volumetric progression was negatively correlated with the original extent of resection and positively correlated with postoperative residual tumor volume (P = .01, P < .001, respectively). CONCLUSION: Intended near-total removal results in excellent preservation of facial nerve function and has a low recurrence rate. Any progressive residual tumor may be treated by radiosurgery.
BACKGROUND: The goals of treating Koos grade IV vestibular schwannomas are to relieve brainstem compression, preserve or restore neurological function, and achieve long-term tumor control while minimizing tumor- and treatment-related morbidity. OBJECTIVE: To propose a treatment paradigm involving the intentional near-total removal of Koos grade IV vestibular schwannomas, in which a small amount of residual tumor is not dissected off the cisternal portion of the facial nerve. Patients are then followed by a wait-and-scan approach. Any subsequent volumetric progression of the residual tumor is treated with radiosurgery. METHODS: This is a case series of 44 consecutive unselected patients who underwent intended near-total resection of a Koos grade IV vestibular schwannoma through a retrosigmoid approach from January 2009 to December 2015. Pre- and postoperative volumetric analyses were performed on routine magnetic resonance imaging sequences (constructive interference in steady state and gadolinium-enhanced T1-weighted sequence). RESULTS: The mean preoperative tumor volume was 10.9 cm3. The mean extent of resection was 89%. At the last clinical follow-up, facial nerve function was good [House and Brackmann (HB) I-II] in 89%, fair (HB III) in 9%, and poor (HB IV-VI) in 2% of the patients. At the last radiological follow-up, the residual tumor had become smaller or remained the same size in 84% of patients. Volumetric progression was negatively correlated with the original extent of resection and positively correlated with postoperative residual tumor volume (P = .01, P < .001, respectively). CONCLUSION: Intended near-total removal results in excellent preservation of facial nerve function and has a low recurrence rate. Any progressive residual tumor may be treated by radiosurgery.
Authors: Luciano Mastronardi; Alberto Campione; Guglielmo Cacciotti; Ettore Carpineta; Carlo Giacobbo Scavo; Raffaele Roperto; Giovanni Stati; Albert A Sufianov; Karl Schaller Journal: Neurosurg Rev Date: 2021-08-17 Impact factor: 3.042
Authors: Paolo di Russo; Arianna Fava; Alberto Vandenbulcke; Akinori Miyakoshi; Michihiro Kohno; Alexander I Evins; Vincenzo Esposito; Roberta Morace Journal: Neurosurg Rev Date: 2020-04-07 Impact factor: 3.042
Authors: Kathleen Seidel; Matthias S Biner; Irena Zubak; Jonathan Rychen; Jürgen Beck; Andreas Raabe Journal: Neurosurg Rev Date: 2018-10-26 Impact factor: 3.042
Authors: Won Jae Lee; Jung Il Lee; Jung Won Choi; Doo Sik Kong; Do Hyun Nam; Yang Sun Cho; Hyung Jin Shin; Ho Jun Seol Journal: J Korean Med Sci Date: 2021-04-26 Impact factor: 2.153
Authors: Mohamed H Khattab; Alexander D Sherry; Nauman Manzoor; Douglas J Totten; Guozhen Luo; Lola B Chambless; Alejandro Rivas; David S Haynes; Anthony J Cmelak; Albert Attia Journal: J Neurol Surg B Skull Base Date: 2020-05-26